CareDx to Participate in Upcoming Investor Conferences

Audio By Carbonatix

BRISBANE, Calif.--(BUSINESS WIRE)--Nov 10, 2025--

CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences:

• Stephens Investment Conference in Nashville, TN. Fireside chat on Wednesday, November 19, 2025, at 8am CT.
• Piper Sandler Healthcare Conference in New York, NY. Presentation on Wednesday, December 3, 2025, at 4:30pm ET.

Live and archived webcasts of the presentations will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit www.caredx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251110292221/en/

CONTACT: Investor Relations

Caroline Corner

[email protected]

KEYWORD: TENNESSEE CALIFORNIA NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY SURGERY MEDICAL DEVICES HEALTH PHARMACEUTICAL

SOURCE: CareDx, Inc.

Copyright Business Wire 2025.

PUB: 11/10/2025 08:00 AM/DISC: 11/10/2025 08:01 AM

http://www.businesswire.com/news/home/20251110292221/en